Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Controlling the Polarity of Ag:PSS Polyelectrolyte Interfacial Layers in Organic Solar Cells.

ACS omega·2026
Same author

A human liver organoid platform for hepatotoxicity assessment: evaluation using reference compounds.

Frontiers in toxicology·2026
Same author

Correction: Comprehensive performance assessment of the BMIA-12 a system for bone marrow cell quantification in normal and hematological malignancy samples.

Scientific reports·2026
Same author

Usability Testing of a Hair Apposition Device for Scalp Laceration: A Manikin Simulation Study.

Emergency medicine international·2026
Same author

A novel approach for enhancing the potency of kinase inhibitors using topological water networks.

Journal of cheminformatics·2026
Same author

Analyses of receptor binding specificity of highly pathogenic avian influenza A (H5N1) viruses isolated from felines in South Korea, 2023.

Virulence·2026

Related Experiment Video

Updated: Jul 7, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Docking-based 3D-QSAR study for 11beta-HSD1 inhibitors.

Jin Hee Lee1, Nam Sook Kang, Sung-Eun Yoo

  • 1Center for Drug Discovery Technologies, Korea Research Institute of Chemical Technology, Yu seong-gu, Daejon 305-600, Republic of Korea.

Bioorganic & Medicinal Chemistry Letters
|March 4, 2008
PubMed
Summary

Three-dimensional quantitative structure-activity relationship (3D-QSAR) studies on 70 inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) were performed. These studies successfully predicted the activity of new 11beta-HSD1 inhibitors.

More Related Videos

Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology
08:44

Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology

Published on: May 19, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Related Experiment Videos

Last Updated: Jul 7, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology
08:44

Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology

Published on: May 19, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Enzyme Inhibition

Background:

  • 11beta-Hydroxysteroid dehydrogenase (11beta-HSD) enzymes are crucial for steroid hormone activity.
  • 11beta-HSD1 is a key target for treating metabolic diseases like diabetes and obesity.
  • Understanding structure-activity relationships is vital for developing effective inhibitors.

Purpose of the Study:

  • To establish a correlation between the structure of 11beta-HSD1 inhibitors and their activity.
  • To develop predictive 3D-QSAR models for novel 11beta-HSD1 inhibitors.
  • To guide the design of new therapeutic agents targeting 11beta-HSD1.

Main Methods:

  • Performed 3D-QSAR studies on 70 known 11beta-HSD1 inhibitors.
  • Utilized molecular docking conformations generated by FlexX-Pharm.
  • Applied comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA).

Main Results:

  • Developed highly predictive 3D-QSAR models with q(2) values of 0.543 (CoMFA) and 0.519 (CoMSIA).
  • Demonstrated a good correlation between 3D-QSAR field contributions and the enzyme's binding site structural features.
  • Validated the predictive power of the developed models.

Conclusions:

  • The 3D-QSAR models provide a reliable framework for predicting the activity of new 11beta-HSD1 inhibitors.
  • These findings can accelerate the discovery of novel drug candidates for metabolic disorders.
  • The study highlights the utility of computational approaches in drug design for enzyme targets.